1. Angiotensin II (AngII) evokes a variety of physiological responses
in the adrenal gland, It is the major regulator of aldosterone secreti
on, in the medulla it enhances catecholamine release and it exerts tro
phic effects in the adrenal and stimulates growth factor secretion, 2.
Angiotensin II acts via binding to specific receptors, located on the
plasma membrane, Two pharmacologically distinct AngII receptor subtyp
es, type 1 (AT(1)) and type 2 (AT(2)) receptors, have been identified
using the non-peptide antagonists Dup753 and PD 123177, respectively,
and cDNA encoding each type have been identified, 3, In the adrenal, t
he AT(1) receptor modulates all the known biological effects of AngII.
The expression of the AT(1) receptor is modulated at the mRNA and pro
tein levels by many factors: conditions that increase levels of AngII
(low sodium diet, renovascular hypertension, AngII infusion) up-regula
te AT(1) receptor mRNA levels and binding and increase aldosterone sec
retion. 4, A tissue renin-angiotensin system has been found in the adr
enal, suggesting an important paracrine role for AngII in aldosterone
regulation, 5. The possible involvement of AT(1) receptors in human di
sease has been investigated by examining the role of AngII receptors i
n adrenal tumours. Binding and gene expression studies have shown that
AngII receptors are abundantly expressed in aldosterone-producing ade
noma (APA), 6. Densitometric analysis of AT(1) expression in APA showe
d no significant differences compared with normal and nontumorous adre
nal. In addition, no mutations in the coding sequence of the AT(1) rec
eptor have been found to date in adrenal tumours.